BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2026 6:54:16 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-03-16 03:42 |
|
Peer-Review Started |
|
2026-03-16 03:43 |
|
First Decision by Editorial Office Director |
|
2026-04-21 09:15 |
|
Return for Revision |
|
2026-04-21 09:15 |
|
Revised |
|
2026-05-12 18:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-06-10 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-17 07:19 |
|
Articles in Press |
|
2026-06-17 07:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-06 09:10 |
|
Publish the Manuscript Online |
|
2026-08-20 06:54 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Review |
| Article Title |
Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Heba Adel Abd El Ghaffar, Aya Mohamed Adel Arafat, Eman Hazem AbdelTawab Khattab, Mustafa Ashraf Khattab, Ahmed M Khallaf and Shirihan Mahmoud Anwar Mahgoub |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Aya Mohamed Adel Arafat, Lecturer, MD, Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Al-Saray Street, Cairo 11956, Egypt. aya.arafat@kasralainy.edu.eg |
| Key Words |
Artificial intelligence; Hematopoietic stem cells; Machine learning; Deep learning; Drug discovery; Biological products; Automation; Acute myeloid leukemia; Multiple myeloma |
| Core Tip |
Artificial intelligence is redefining the study of hematopoietic stem cells (HSCs) by serving as a computational guide to stemness biology. Machine learning and deep learning delineate HSC fate trajectories, unravel age-dependent HSC self-renewal, and identify enriched leukemic stem cell sub-compartments that sustain treatment-resistant leukemia and relapse in acute myeloid leukemia and multiple myeloma. The same approaches expedite leukemic stem cell-targeted drug discovery, model HSC biomanufacturing for digital twins and predict transplant risk using natural language processing. High-performing artificial intelligence models are therefore quantitative surrogates for stem cell state - and span single-cell biology and decision-making across the HSC continuum. |
| Publish Date |
2026-08-20 06:54 |
| Citation |
Abd El Ghaffar HA, Arafat AMA, Khattab EHA, Khattab MA, Khallaf AM, Mahgoub SMA. Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing. World J Stem Cells 2026; 18(8): 121077
|
| URL |
https://www.wjgnet.com/1948-0210/full/v18/i8/121077.htm |
| DOI |
https://doi.org/10.4252/wjsc.121077 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
